TNF Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
TNF Pharmaceuticals has a total shareholder equity of $17.1M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $24.0M and $7.0M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$10.64m |
| Equity | US$17.06m |
| Total liabilities | US$6.99m |
| Total assets | US$24.04m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0A8D's short term assets ($12.0M) exceed its short term liabilities ($7.0M).
Long Term Liabilities: 0A8D has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: 0A8D is debt free.
Reducing Debt: 0A8D currently has no debt however we can't compare to 5 years ago as we have no data for that period.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 0A8D has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 0A8D is forecast to have sufficient cash runway for 11 months based on free cash flow estimates, but has since raised additional capital.